RRI

Advances in CKD 2006 (RRI Conference, Las Vegas, NV, January, 2006).
(Lecture handouts of dialysis adequacy talks by John Burkart, MD; Gerald Schulman, MD; Claudio Ronco, MD; Eberhard Ritz, MD; Alp Ikizler, MD; Takahiko Nakagawa, MD, and Frank Gotch, MD.)

Bukart: The Significance of Residual Renal Function – Is it the Pee or the Bean? Schulman: New Important Technologies. Oral Sorbents in Uremia: Early Results. Ronco: Hemodiafiltration (HDF) – A Critical Evaluation of its Value. Ritz: KEYNOTE ADDRESS: SODIUM AS A UREMIC TOXIN Ikizler, Nakagawa: Uric Acid - A Uremic Toxin? Gotch: Dialysis Kinetics Q & A. (more...)



key Try Dr. Daugirdas' QUIZ: Solute Molecular Weight, Diffusion, Ultrafiltration, and Flux. This is the second in the Basic Dialysis Quiz Series. In fact, the first quiz should be considered a pre-requisite. What is the effect of solute molecular weight on diffusive transport? On transport by ultrafiltration? What is a high efficiency vs. a high-flux dialyzer? What are the relative transport rates for urea and beta-2-microglobulin with these dialyzers?
Note: Feedback sections of this quiz will work ONLY with internet explorer and not with Firefox.

key Try Dr. Daugirdas' QUIZ: Basics of Dialyzer Function: Extraction ratio and clearance. What is the dialyzer extraction ratio (ER)? How is the ER used to derive dialyzer clearance? How do blood and dialysate flow affect the extraction ratio and clearance? What is the dialyzer mass transfer area coefficient (K0A)? How does use of twin dialyzers in series or parallel improve extraction ratio and clearance? When does the dialyzer size matter?.?
Note: Feedback sections of this quiz will work ONLY with internet explorer and not with Firefox.

Updated: May 05, 2008 (M05)
M05 ASN Renal Week abstract archives 2003-2006 now available on-line in .pdf format.
A15 CMS adopts 26 new CPMs effective April 1, 2008
M02 Early start? How about very late start in patients over 70 with very low protein diet?
F04 Annual Dialysis Conference 2007 abstracts (Denver, Feb 18-20, 2007)
N26 HDCN: Search index updated for audiofiles, slide/audio talks, articles, and abstracts
J16 CARI (Australasian) Clinical Practice Guidelines published (53 free full text review papers!)
N11 JASN Express: Skin autofluorescence linked to AGE in ESRD, predicts mortality.
O26 ASN Renal Week 2005 abstracts now available on-line.
O20 U.S. Japanese and other U.S. Asian dialysis patients live longer.
S29 JASN: Dose-targeting bias may confound Kt/V vs. mortality relationship.
J17 Nephros gets FDA OK to market mid-dilution HDF filter in the United States.
J07 FMC: Fresenius unveils new 5008 HD-HDF machine ýn Istanbul.
J07 FMC: European registry data shows 35% lower death risk wýth hemodiafiltration
M14 Nephros files with FDA for approval of high-efficiency hemodiafilter.
D16 ANNA: Learning module, PPT files, CE on Hemodialysis
Industry Advances Emphasis
archive
What Do We Know About Uremic Toxins? (William R. Clark, MD; Bernard J. Canaud, MD; Thomas A. Depner, MD; Muriel P.C. Grooteman, MD, PhD) ADC 2006 (audio only)
Emerging Dialysis Techniques (Derrick Latos, MD; Robert S. Lockridge, Jr., MD) ADC 2006 (audiofiles)
Solute Kinetics 101, or Understanding Kinetic Modeling for the Non-Mathematician (Ting) ADC 2006 - (audio only)
The Significance of Residual Renal Function – Is it the Pee or the Bean? (Burkart) RRI 2006 - Part 3 (handout only)
New Important Technologies. Oral Sorbents in Uremia: Early Results (Schulman) RRI 2006 - Part 3 (handout only)
Hemodiafiltration (HDF) – A Critical Evaluation of its Value (Ronco) RRI 2006 - Part 2 (handout only)
Sodium as a Uremic Toxin (Ritz) RRI 2006 - Part 2 (handout only)
Uric Acid as a Uremic Toxin (Ikizler, Nakagawa) RRI 2006 - Part 2 (handout only)
Dialysis Kinetic Q and A (Gotch) RRI 2006 - Part 1 (handout only)
The Uremic Syndrome (Vanholder) ASN Renal Week 2005 (audio only)
Clinical Trials in Dialysis: An Appraisal of Results and Ongoing Trials (Cheung) ASN Renal Week 2005 (audio only)
Renal Replacement Therapy in ARF -- Timing and Dose of Therapy (Palevsky) ASN Renal Week 2005 (audio only)
Determinants of Diffusive and Convective Solute Transport (Clark) ASN Renal Week 2005 (audio only)
Assessment of Dialysis Adequacy Using Urea Kinetics (Depner) ASN Renal Week 2005 (audio only)
DEBATE: Are practice patterns the prime factors responsible for mortality differences between Europe, Japan and USA? (Kuhlmann vs. Young) RRI 2005 (audio only)
Dialysis Adequacy vs. Mortality: Implications of Dose — Targeting Biases (Daugirdas) RRI 2005 (audio only)
Hemodiafiltration (HDF): Theory, Quantification, Clinical Management (Canaud, Clark, Kjellstrand, Traeger, Akiba) ADC 2005 (audio only)
Preservation of residual renal function in hemodialysis patients (Lameire) ASN Renal Week 2005
Dialysis Dose: Measurement, prescription and delivery - case discussions (Paganini) ASN Renal Week
Peritoneal dialysis adequacy: what is the role of ADEMEX? (Mujais) NKF 2002 Spring Meeting
How should ADEMEX affect PD practice in the United States? (Teitelbaum) NKF 2002 Spring Meeting
Kt/V, body mass determinants, and survival (Daugirdas) ASN/ISN 2001 Meeting
Physician extenders in the dialysis unit (Bolton) RPA 2001 Annual Meeting

Major Difficulties the US Nephrologist Faces in Providing Adequate Dialysis (Diaz-Buxo and Crawford-Bonadio) Blood Purification 01-07
International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. (Yoshino et al.) JASN 12-06
Should dialysis patients ever receive warfarin and for what reasons? (Bennett) CJASN 11-06
DOQI HD GUIDELINES
2006 Hemodialysis Adequacy Update
HDCN Topic Pages
Physiology of HD
Dialyzers
Modeling, Adequacy
Dialysis Outcomes
Complications
HDCN Calculators
Standard Kt/V
Body Surface area and BSA
What is the Kt/V, PCRn, and V?
Initial dialysis session length
Dialysis session length, V known
Dialyzer K0A
Batch calculator (KEY)
Dialyzer Table (KEY)
Dialyzer Table by Co. (KEY)
LINKS
Dialysis Facility COMPARE
DOPPS
HCFA Clin Perf Measures
NIH Patient Info on Dose
U Mich Kidney Epid Center
USRDS
European Uremic Toxin Workgroup (EUTox)

Dr. John Daugirdas, M.D.
Clinical Professor of Medicine, University of Illinois at Chicago, IL.